ALOQUEN

WIPO WIPO 2021

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke ALOQUEN wurde als Wortmarke am 19.11.2021 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 04. Juli 2023

Markenform Wortmarke
Aktenzeichen 1656183
Länder Australien Kanada Schweiz China Europäische Gemeinschaft Großbritannien Israel Indien Japan Südkorea
Basismarke US Nr. 90730427, 24. Mai 2021
Anmeldedatum 19. November 2021
Ablaufdatum 19. November 2031

Markeninhaber

214 Sullivan Street, Suite 6C
New York NY 10012
US

Markenvertreter

P.O. Box 1022 Minneapolis MN 55440-1022 US

Waren und Dienstleistungen

09 Downloadable computer application software for managing, administering, and monitoring medication adherence; downloadable computer application software for monitoring patient behavior; downloadable computer software for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; electronic downloadable publications in the nature of data, findings, evaluations, and reports in the field of medicine and pharmacology
42 Providing online non-downloadable software for managing, administering, and monitoring of medication adherence; providing online non-downloadable software for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; software as a service (SASS) services, namely, hosting software that enables health care providers, clinical trial personnel, and clinical trial sponsors to administer medication adherence programs, monitor patient behavior, and enable remote patient engagement providing online non-downloadable open source software for measuring patient behavior; platform as a service (PAAS) featuring artificial intelligence for use in drug development and analysis; platform as a service (PAAS) featuring artificial intelligence for use in performing analysis of medical and pharmaceutical data and providing insights into that data; platform as a service (PAAS) featuring artificial intelligence for use in computer vision model development; platform as a service (PAAS) featuring artificial intelligence for self-service data analysis processing in the field of medicine and pharmacology
44 Providing medical analysis services, namely, monitoring medication intake for purposes of analyzing medical treatment adherence; patient medication care management and medication adherence services, namely, communicating with patients regarding their medications and adherence to medication regimens for medical treatment and clinical research purposes; medication adherence programs, namely, interactive medical monitoring and alert service for reminding clients of medicinal dosage for medical treatment and clinical research purposes; providing medical information and medical monitoring information from remote locations via the Internet and telecommunication networks via patient monitoring devices that feed information to a website that can be accessed in real-time by medical professionals; providing medical information in the nature of an online medical profile and medical record analysis service designed to provide patients and medical professionals with custom tailored information regarding medication adherence via a website; providing interactive medical monitoring and alert service for reminding patients of medication dosages and medication adherence for medical treatment and clinical research purposes
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
29. Juni 2023 2023/27 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
22. Februar 2023 2023/8 Gaz CH Ablehnung
26. Januar 2023 2023/4 Gaz JP Ablehnung
02. Januar 2023 2023/2 Gaz IL Ablehnung
12. Dezember 2022 2022/51 Gaz IN Ablehnung
13. Oktober 2022 2022/41 Gaz CN Ablehnung
07. September 2022 2022/36 Gaz EM Ablehnung
20. Juli 2022 2022/30 Gaz GB Ablehnung
29. Juni 2022 2022/27 Gaz AU Ablehnung
19. November 2021 2022/13 Gaz US Eintragung

ID: 141656183